Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer. [electronic resource]
Producer: 20030109Description: 903-9 p. digitalISSN:- 0923-7534
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Confidence Intervals
- Docetaxel
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Drug-Related Side Effects and Adverse Reactions
- Female
- Filgrastim
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Injections, Subcutaneous
- Middle Aged
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Polyethylene Glycols
- Probability
- Recombinant Proteins
- Reference Values
- Taxoids
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.